297 related articles for article (PubMed ID: 12019161)
1. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
[TBL] [Abstract][Full Text] [Related]
2. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.
Matsushita S; Nitanda T; Furukawa T; Sumizawa T; Tani A; Nishimoto K; Akiba S; Miyadera K; Fukushima M; Yamada Y; Yoshida H; Kanzaki T; Akiyama S
Cancer Res; 1999 Apr; 59(8):1911-6. PubMed ID: 10213500
[TBL] [Abstract][Full Text] [Related]
3. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose.
Nakajima Y; Gotanda T; Uchimiya H; Furukawa T; Haraguchi M; Ikeda R; Sumizawa T; Yoshida H; Akiyama S
Cancer Res; 2004 Mar; 64(5):1794-801. PubMed ID: 14996742
[TBL] [Abstract][Full Text] [Related]
5. 2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9.
Nakajima Y; Haraguchi M; Furukawa T; Yamamoto M; Nakanishi H; Tatematsu M; Akiyama S
Int J Cancer; 2006 Oct; 119(7):1710-6. PubMed ID: 16646076
[TBL] [Abstract][Full Text] [Related]
6. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis.
Stevenson DP; Milligan SR; Collins WP
Am J Pathol; 1998 Jun; 152(6):1641-6. PubMed ID: 9626068
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-deoxy-D-ribose.
Ikeda R; Furukawa T; Kitazono M; Ishitsuka K; Okumura H; Tani A; Sumizawa T; Haraguchi M; Komatsu M; Uchimiya H; Ren XQ; Motoya T; Yamada K; Akiyama S
Biochem Biophys Res Commun; 2002 Mar; 291(4):806-12. PubMed ID: 11866437
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma.
Yu EJ; Lee Y; Rha SY; Kim TS; Chung HC; Oh BK; Yang WI; Noh SH; Jeung HC
Mol Cancer Res; 2008 Oct; 6(10):1554-66. PubMed ID: 18922971
[TBL] [Abstract][Full Text] [Related]
9. 2-Deoxy-D-ribose, a downstream mediator of thymidine phosphorylase, regulates tumor angiogenesis and progression.
Nakajima Y; Madhyastha R; Maruyama M
Anticancer Agents Med Chem; 2009 Feb; 9(2):239-45. PubMed ID: 19199868
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration.
Hotchkiss KA; Ashton AW; Klein RS; Lenzi ML; Zhu GH; Schwartz EL
Cancer Res; 2003 Jan; 63(2):527-33. PubMed ID: 12543812
[TBL] [Abstract][Full Text] [Related]
11. [Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors].
Miszczak-Zaborska E; Smolarek M; Bartkowiak J
Postepy Biochem; 2010; 56(1):61-6. PubMed ID: 20499682
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase.
Kitazono M; Takebayashi Y; Ishitsuka K; Takao S; Tani A; Furukawa T; Miyadera K; Yamada Y; Aikou T; Akiyama S
Biochem Biophys Res Commun; 1998 Dec; 253(3):797-803. PubMed ID: 9918807
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of the antitumor activity of alpha, alpha, alpha-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo.
Emura T; Suzuki N; Fujioka A; Ohshimo H; Fukushima M
Int J Oncol; 2005 Aug; 27(2):449-55. PubMed ID: 16010427
[TBL] [Abstract][Full Text] [Related]
14. Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy.
Seeliger H; Guba M; Koehl GE; Doenecke A; Steinbauer M; Bruns CJ; Wagner C; Frank E; Jauch KW; Geissler EK
Clin Cancer Res; 2004 Mar; 10(5):1843-52. PubMed ID: 15014039
[TBL] [Abstract][Full Text] [Related]
15. The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.
Akiyama S; Furukawa T; Sumizawa T; Takebayashi Y; Nakajima Y; Shimaoka S; Haraguchi M
Cancer Sci; 2004 Nov; 95(11):851-7. PubMed ID: 15546501
[TBL] [Abstract][Full Text] [Related]
16. [Thymidine phosphorylase and angiogenesis].
Akiyama S
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1208-11. PubMed ID: 10945018
[TBL] [Abstract][Full Text] [Related]
17. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
Xiao YS; Zhou J; Tang ZY; Fan J; Wu ZQ; Liu YK; Ye SL; Shen ZZ; Xue Q; Zhao Y
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3205-9. PubMed ID: 16405841
[TBL] [Abstract][Full Text] [Related]
18. Thymidine phoshorylase as a target for antiangiogenesis treatment.
Peters GJ; Bijnsdorp IV; Fukushima M
Nucleic Acids Symp Ser (Oxf); 2008; (52):629. PubMed ID: 18776537
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study.
Fox SB; Moghaddam A; Westwood M; Turley H; Bicknell R; Gatter KC; Harris AL
J Pathol; 1995 Jun; 176(2):183-90. PubMed ID: 7636628
[TBL] [Abstract][Full Text] [Related]
20. Influence of platelet-derived endothelial cell growth factor/thymidine phosphorylase on the cell cycle in head and neck squamous cell carcinoma in vitro.
Igawa H; Fujieda S; Kimura Y; Sugimoto C; Tanaka N; Ohtsubo T; Kato Y; Saito H
Oncol Rep; 2003; 10(4):967-71. PubMed ID: 12792754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]